In this StockCharts TV video, Mary Ellen reviews the broader markets, takes a close look at NVDA and other year-to-date winners that sold off last week, and shares top candidates in…
Stock
Moving averages are a crucial charting tool, but many of us aren’t getting the most out of them. In this edition of StockCharts TV‘s StockCharts in Focus, Grayson shows you how to…
Who would have thought a mid-week break would halt the stock market’s winning streak? Maybe the hot PMI reading leaked, or traders and investors felt the stock market was getting…
In this edition of StockCharts TV‘s The Final Bar, Dave recaps a day where technology shares struggles, with leading names like NVDA and MU dropping bearish engulfing patterns to indicate short-term distributions.…
In this edition of StockCharts TV‘s The Final Bar, Dave answers viewer questions on using technical indicators on leveraged and inverse ETFs like SOXL and SOXS, buying breakouts below the 200-day moving…
Editor’s Note: This article was originally published on November 21, 2022. This article has absolutely nothing to do with trend following or the markets. I have two friends; one whose…
Gilead Sciences’ (GILD) new HIV prevention shot, lenacapavir, hit it out of the park in a late-stage trial, showing 100% effectiveness. 2,000 women participated in the trial, and none of…
Today on Fox Business Varney & Company, David Bahnsen (The Bahnsen Group) was asked if the current market reminded him of the Dot.com Bubble. He said it did, but not…
While the S&P 500 continues to move higher, the number of stocks participating to the upside continues to decline. In other words, market breadth is deteriorating. However, it has been…
Note to the reader: This is the twenty-fifth and final in a series of articles I’m publishing here, taken from my book, “Investing with the Trend.” Hopefully, you will find…